Univdatos Whatsapp
GLOBAL TRANSPLANT DIAGNOSTICS MARKET

GLOBAL TRANSPLANT DIAGNOSTICS MARKET IS EXPECTED TO FORESEE SIGNIFICANT GROWTH DURING THE FORECAST PERIOD. NORTH AMERICA TO WITNESS THE HIGHEST GROWTH

Global Transplant Diagnostics Market is expected to reach the market valuation of USD 5.4 billion by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from USD 3.8 billion in 2019. Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after transplant.

The various factors driving the Transplant Diagnostics market include the increasing organ transplantation and the growing number of geriatric populations. As per Statista, in 2019, the rate of patients having transplanted organs in several nations around the world. During this year, France had a rate of roughly 87 organ transplant patients per million inhabitants. If blood and oxygen are flowing through the organs until the moment of recovery, organ donation can be done by both a deceased and a living donor. The increased rate of organ transplantation is due to the increase in diseases causing severe organ damages. This has been boosting the demand for diagnostic transplants.

For a detailed analysis of the market drivers in Transplant Diagnostics browse through – https://univdatos.com/report/transplant-diagnostics-market

The COVID19 has resulted in a profound re-evaluation of the advantages and costs of organ and tissue transplants. The pandemic has been a devastating disease worldwide. Although an important number of young healthy people have been affected, elderly, comorbid and immunosuppressed patients have been especially compromised. For instance, the largest report up until September 30, 2020, came from the COVID-19 and Cancer Consortium (CCC19), that reported 30-day all-cause mortality for 928 patients from the United States, Canada, and Spain with laboratory confirmed SARS-CoV-2 and a diagnosis of invasive or hematologic malignancy between March 17, and April 16, 2020. Furthermore, there has been speculation of a correlation between immune-related adverse events and severe COVID-19. This has also resulted in organ failure in patients suffering from COVID-19 and other sever infectious diseases.  For instance, as per Human Resource and Service administration (HRSA), 39,000 transplants were performed in 2020 in the USA.

For a detailed analysis of the COVID-19 Impact on Transplant Diagnostics browse through – https://univdatos.com/report/transplant-diagnostics-market

Based on technology, the market is fragmented into molecular assay technologies, PCR-based molecular assays, sequencing based molecular assays, and non-molecular assay technologies. The molecular assays technologies segment dominated the market in 2020 and generated the total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.

The application wherein transplant diagnostics is utilized includes fragmented diagnostic applications and research applications. In 2020, diagnostic applications segment accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.

For a detailed analysis of the technology in Transplant Diagnostics browse through – https://univdatos.com/report/transplant-diagnostics-market

Based on end-user, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories segment dominated the market in 2020 and generated the total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period. Moreover, the segment is also expected to witness highest CAGR during the analyzed period.

Additionally, the report provides detailed initiatives that are being taken in the field of Transplant Diagnostics. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD 37.56 billion in 2020 owing to the increasing cancer incidence and higher healthcare spending.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/480

TE Connectivity, HARTING, HIROSE, Würth Electronics, Phoenix Contact, Softing AG, Belden, LEONI, and MURR Elektronik are some of the prominent players operating in the global Transplant Diagnostics market. Several M&A’s along with partnerships have been undertaken by these players to develop Transplant Diagnostics.

Global Transplant Diagnostics Market Segmentation

Market Insight, by Technology

  • Molecular assay technologies
    • PCR-based molecular assays
    • Sequencing based molecular assays
  • Non-molecular assay technologies

Market Insight, by Product & Service

  • Reagents & consumables
  • Instruments
  • Software & Services

Market Insight, by Transplant type

  • Solid organ transplantation
  • Stem cell transplantation
  • Soft tissue transplantation
  • Bone marrow transplantation

Market Insight, by Application

  • Diagnostic application
  • Pre transplantation diagnostics
  • Post transplantation diagnostics
  • Research applications

Market Insight, by End-User

  • Independent reference laboratories
  • Hospitals & transplant centers
  • Research laboratories & academic institutes

Market Insight, by Region

  • North America
    • United States
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Bio-Rad Laboratories, Inc.
  •  F. Hoffman-La Roche Ltd.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  •  bioMérieux S.A.
  • Immucor, Inc.
  • Illumina, Inc.
  •  Luminex Corporation
  • Becton, Dickinson and Company
  • BAG Healthcare

Leave A Comment

Select Language